-
Potential 21% Upside Seen For Shares Of Recent IPO Penumbra
Monday, October 17, 2016 - 1:16pm | 301Read More...BMO Capital Markets started coverage of Penumbra Inc (NYSE: PEN) with an Outperform rating and price target of $86, implying potential upside of 21 percent. Although it's a recent IPO, the brokerage pointed out that the company’s 2015 revenue rose 53 percent to $186 million, including...
-
Cooper Companies Third Quarter Good, Not Great, Says BMO
Friday, September 2, 2016 - 11:25am | 338Read More...Cooper Companies Inc (NYSE: COO) reported its third-quarter results after Thursday's market close. The company said it earned $2.30 per share in the quarter on revenue of $514.7 million, exceeding the $2.29 per share and $511.8 million Wall Street analysts were expecting. According to Joanne...
-
Expect Conservative Guidance For Medical Tech Stocks?
Friday, January 22, 2016 - 12:11pm | 497Read More...On Thursday, BMO Capital Markets issued a report on the Medical Technology industry ahead of the fourth quarter earnings season. Analysts highlighted multiple companies including Abbott Laboratories (NYSE: ABT), Wright Medical Group Inc. (NASDAQ: WMGI), and Stryker Corporation (NYSE: SYK). Joanne...
